Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 196

Results For "CE"

8537 News Found

Siegfried breaks ground on new R&D center for drug substances in Switzerland
News | April 26, 2023

Siegfried breaks ground on new R&D center for drug substances in Switzerland

The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth


Boehringer Ingelheim inaugurates largest European development centre for biotechnology
News | April 25, 2023

Boehringer Ingelheim inaugurates largest European development centre for biotechnology

New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists


Sun Pharma launches CEQUA, a novel therapy for Dry Eye Disease in India
News | April 25, 2023

Sun Pharma launches CEQUA, a novel therapy for Dry Eye Disease in India

CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology


Zydus receives final approval from the USFDA for Metronidazole Topical Cream
Drug Approval | April 25, 2023

Zydus receives final approval from the USFDA for Metronidazole Topical Cream

Metronidazole is an antibiotic used on the skin to treat a certain skin disorder known as rosacea


Indica Labs and Lunit enters into alliance for digital pathology AI workflows
Digitisation | April 25, 2023

Indica Labs and Lunit enters into alliance for digital pathology AI workflows

Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution


Zydus receives final approval from the USFDA for Icosapent Ethyl Capsules
Drug Approval | April 24, 2023

Zydus receives final approval from the USFDA for Icosapent Ethyl Capsules

Icosapent Ethyl Capsules are indicated as an adjunct to diet to reduce triglyceride levels


USFDA suggests corrective measures to Sun Pharmaceutical’s Mohali facility
Drug Approval | April 24, 2023

USFDA suggests corrective measures to Sun Pharmaceutical’s Mohali facility

The USFDA had classified the inspection as "Official Action Indicated" (OAI).


LTS acquires Sorrel wearable injection device business
News | April 22, 2023

LTS acquires Sorrel wearable injection device business

The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.


Sai Life Sciences opens research facility SSRL
News | April 22, 2023

Sai Life Sciences opens research facility SSRL

Fully equipped labs with 75-member team set-up and made operational in <100 days


Ajinomoto Bio-Pharma receives FDA approval for high potency fill line
Drug Approval | April 22, 2023

Ajinomoto Bio-Pharma receives FDA approval for high potency fill line

Aji Bio-Pharma has six fill finish lines located in San Diego, including a new line